Janus Living, Inc. 8-K

What Happened

• Janus Living, Inc. announced it closed a registered underwritten public offering of 25,000,000 shares of Class A‑1 common stock on or around June 2, 2026. The company also granted the underwriters a 30‑day option to purchase up to an additional 3,750,000 shares.
• The company entered into an Underwriting Agreement dated June 2, 2026, among Janus Living, Janus Living OP, LLC (the Operating Company), Healthpeak Investment Management, LLC (the Manager), and representatives of the underwriters: BofA Securities, J.P. Morgan Securities, RBC Capital Markets and Wells Fargo Securities. The Underwriting Agreement (filed as Exhibit 1.1) includes customary representations, covenants, closing conditions and indemnification provisions.

Key Details

• Shares sold: 25,000,000 shares of Class A‑1 common stock.
• Underwriter option: 30‑day option to purchase up to 3,750,000 additional shares.
• Agreement date and filing: Underwriting Agreement dated June 2, 2026; offering made under Form S‑11 (File No. 333‑296384). The Underwriting Agreement is included as Exhibit 1.1 to the 8‑K.
• Financial terms (price per share and gross proceeds) are not disclosed in this 8‑K excerpt.

Why It Matters

• The offering raises capital for Janus Living, which can fund operations, growth or other corporate needs; investors should look for follow-up disclosures (e.g., final proceeds) for the company’s use of funds.
• Issuing new shares dilutes existing shareholders’ ownership; the potential additional 3,750,000 shares increases possible dilution.
• The transaction was managed by major investment banks and involves the company’s external manager, Healthpeak Investment Management, which is material context for governance and investor relations.
• The full underwriting agreement is filed as an exhibit for investors who want the detailed terms and legal protections provided to underwriters.